Papers

1

Total Citations

9

H-Index

1

About

Shenghui Wu is a surgical outcomes researcher whose work focuses on optimizing minimally invasive approaches to kidney cancer treatment, particularly through partial nephrectomy. His most-cited study, published in 2020, leverages the National Cancer Database to analyze national incidences and predictors of open conversion during minimally invasive partial nephrectomy for cT1 renal masses—a critical area for improving surgical decision-making and patient outcomes. By identifying factors that lead to conversion from laparoscopic or robotic techniques to open surgery, Wu’s research provides actionable insights for urologic surgeons, helping to reduce operative risks and enhance the benefits of nephron-sparing surgery. With 9 citations, this work has already informed clinical practice and sparked further investigation into surgical quality metrics. Wu’s contributions underscore his commitment to evidence-based surgery and large-database analysis, making him a valuable voice in the ongoing effort to refine minimally invasive oncologic procedures and improve renal cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Analyzing National Incidences and Predictors of Open Conversion During Minimally Invasive Partial Nephrectomy for cT1 Renal Masses
9 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: The University of Texas Health Science Center at Houston

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago